SCHEMBL13601325

SCHEMBL13601325

CC(=O)OC1CCN(C2CCN(C(=O)[C@H](C)Cc3cc(C)c4[nH]c(=O)oc4c3)CC2)CC1

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 12/20 0.40
CYP3A4 P08684 5/20 0.40
SMYD3 Q9H7B4 1/20 0.35
RAMP1 O60894 1/20 0.35
CALCA P06881 6/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601324 0.88 CALCRL (0.41) CALCRLCYP3A4CALCACHRM1
SCHEMBL13601530 0.86 KMT2A (0.44) CALCRLCYP3A4CHRM2CHRM4CHRM5
SCHEMBL13601533 0.84 KMT2A (0.39) CALCRLCYP3A4SMYD3CALCACHRM2
SCHEMBL13601380 0.83 CALCRL (0.38) CALCRLCYP3A4CALCACHRM2CHRM4
SCHEMBL13601534 0.82 KMT2A (0.38) CALCRLCYP3A4CALCACHRM2CHRM4
SCHEMBL13601538 0.82 CALCRL (0.37) CALCRLCYP3A4RAMP1CALCACHRM2
SCHEMBL13601492 0.81 CALCRL (0.39) CALCRLCYP3A4CALCACHRM2CHRM4
SCHEMBL13601541 0.81 CALCRL (0.36) CALCRLCYP3A4RAMP1CALCA
SCHEMBL13601535 0.81 KMT2A (0.37) CALCRLCYP3A4CALCACHRM2CHRM4
SCHEMBL13601335 0.81 CALCRL (0.37) CALCRLCYP3A4CALCACHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed